Prognostic Value of Finger Blood Pressure in Arteriovenous Fistula Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-05

Study Completion Date

2020-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this trial is to investigate the prognostic value of monitoring finger blood pressures (FBPs) in predicting the success of surgically created arteriovenous fistula (AVF) for patients with end stage renal disease. The main questions it aims to answer is:

\- Can FBPs predict AVF maturation?

Participants will undergo FBP measurements at pre-op, immediately post-op, 4 weeks and 6 weeks post-AVF creation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Pre-operative Forearm Exercises on Arterial Venous Fistula Maturation and Blood Flow

NCT03886116

End Stage Renal Disease Arteriovenous Fistula

UNKNOWN NA

Pre-Operative Forearm Exercise On Arteriovenous Fistula Mauration

NCT03137680

Arteriovenous Fistula

UNKNOWN NA

Investigating the Role of Luminal Pressure on Arteriovenous Fistula Maturation

NCT04017806

Arteriovenous Fistula

UNKNOWN

Cohort Study on A Following-up System of Native Arteriovenous Fistulae

NCT02880761

Arteriovenous Fistulae

COMPLETED NA

Handgrip Exercise for Arteriovenous Fistula Maturation

NCT01061008

Chronic Kidney Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Renal Disease End-Stage Kidney Disease Dialysis Access Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with End Stage Renal Failure undergoing Arteriovenous Fistula Creation

Group Type EXPERIMENTAL

Finger Blood Pressure Measurement

Intervention Type OTHER

Finger Blood Pressure Measurement were taken from three digits: the thumb (F1), the middle finger (F2), and the little finger (F3) from both arms.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Finger Blood Pressure Measurement

Finger Blood Pressure Measurement were taken from three digits: the thumb (F1), the middle finger (F2), and the little finger (F3) from both arms.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants has documented Chronic Kidney Disease (CKD), determined by Glomerular Filtration Rate (GFR)
* Participant is recommended for renal replacement therapy based on clinical assessment of renal function as well as CKD staging, as documented in clinical notes.
* Haemodialysis was chosen as the most appropriate renal replacement therapy
* Participant is able to consent to the creation of an AVF in preparation for hemodialysis.
* Participant is able to adhere to follow-up assessments of AVF maturation, if applicable.

Exclusion Criteria

* Subject had a previous AVF and is now undergoing surgery for another AVF creation
* Subject has amputation distal to AVF
* Subject is pregnant or planning to conceive
* Participants is unable to consent

Minimum Eligible Age

21 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No